Citation Impact
Citing Papers
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters
2019 StandoutNobel
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
Identification of interferon-stimulated genes that attenuate Ebola virus infection
2020 StandoutNobel
Recognition of aerosol transmission of infectious agents: a commentary
2019
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice
2020
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
2020 Standout
Can Ebola Virus Vaccines Have Universal Immune Correlates of protection?
2018
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors
2011
Outbreaks in Health Care Settings
2016
The effect of temperature on persistence of SARS-CoV-2 on common surfaces
2020
Respiratory virus shedding in exhaled breath and efficacy of face masks
2020 Standout
Ebola haemorrhagic fever
2010
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
2011 StandoutNature
Advances in Virus-Like Particle Vaccines for Filoviruses
2011
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
2012
Transmission dynamics and control of Ebola virus disease (EVD): a review
2014
Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy
2011
Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy
2020 Standout
Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease
2015
SARS-CoV-2 vaccines in development
2020 StandoutNature
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Disease modeling for Ebola and Marburg viruses
2009
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses
2014
Fc receptors in antibody‐dependent enhancement of viral infections
2015
Ebolavirus Glycoprotein Structure and Mechanism of Entry
2009
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Pandemics, tourism and global change: a rapid assessment of COVID-19
2020 Standout
Disease Tolerance as a Defense Strategy
2012 StandoutScience
Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics
2019
Nosocomial Transmission of Emerging Viruses via Aerosol-Generating Medical Procedures
2019
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
A Forward Genetic Strategy Reveals Destabilizing Mutations in the Ebolavirus Glycoprotein That Alter Its Protease Dependence during Cell Entry
2009
The Pathogenesis of Ebola Virus Disease
2016
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Works of Anders Leung being referenced
Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory
2014
Stability of SARS-CoV-2 on critical personal protective equipment
2021
Transmission of Ebola virus from pigs to non-human primates
2012
Randomized Controlled Ferret Study to Assess the Direct Impact of 2008–09 Trivalent Inactivated Influenza Vaccine on A(H1N1)pdm09 Disease Risk
2014
Immunopathogenesis of Severe Acute Respiratory Disease in Zaire ebolavirus-Infected Pigs
2013
Replication, Pathogenicity, Shedding, and Transmission of Zaire ebolavirus in Pigs
2011
Postexposure Treatment of Marburg Virus Infection
2010
Environmental Contamination and Persistence of Ebola Virus RNA in an Ebola Treatment Center
2016
Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
2008
Assessment of the Efficacy of Commercially Available and Candidate Vaccines against a Pandemic H1N1 2009 Virus
2010
Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates
2008
Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
2009